Skip to main content

Hahnemann's proposed residency sale opposed by feds, others

Centers for Medicare and Medicaid Services called Hahnemann's proposed $7.5M deal for its residency program assets with Tower Health "contrary to law."
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.